期刊文献+

爱普列特对大鼠前列腺凋亡相关基因及5α还原酶mRNA表达的影响 被引量:1

Effect of epristeride on expressions of gene related apoptesis and 5 alpha-reductase mRNA in rat prostate
原文传递
导出
摘要 目的评价爱普列特对对大鼠前列腺Bcl-2、Bax、CD34、eNOS及5α还原酶mRNA表达的影响。方法分别给予雄性大鼠爱普列特(爱普列特组)、非那雄胺(非那雄胺组)和生理盐水(正常对照组),观察大鼠Bcl-2、Bax、eNOS、微血管密度(MVD)以及2种5a还原酶mRNA的表达情况。结果爱普列特组Bc1—2、eNOS、MVD(148±42、72.3±48.5、4.6±2.2)与非那雄胺组(152±59、144.8±80.8、4.9±1.3)及正常对照组(216±52、293.9±116.0、8.0±3.0)比较,3个指标均下降(F值分别为6.6、0、26.45、9.52、均P〈0.01);Bax在爱普列特组为(390±167)、非那雄胺组为(311±155),较对照组(185±73)上升(F=6.35,P=0.004),三组Srd5α1及Srd5α2还原酶mRNA的表达差异无统计学意义(F值分别为0.427和0.58,均P〉0.05)。结论爱普列特可以促进前列腺细胞凋亡,抑制血管生成,减少微血管密度,但可能不能影响5a还原酶mRNA的表达,且其作用与非那雄胺相似。 Objective To identify the effect of epristeride on the expressions of Bcl-2, Bax, CD34, eNOS and 5 alpha-reduetase mRNA in rat prostate. Methods Male rats were fed with epritseride, finasteride or physiological saline, respectively. The expressions of Bcl-2, Bax, CD34, eNOS and 5 alpha-reductase mRNA in the prostate tissue were detected and analyzed. Results The expressions of Bcl-2, eNOS and microvessel density (MVD) were lower in epritseride group (148± 42, 72.3±48. 5 and 4. 6±2. 2) and in finasteride group (152±59, 144.8±80.8 and 4.9±1.3) than in physiological saline group (216±52, 293.9±116.0 and 8.0±3.0, F=6.60, 26.45 and 9.52 respectively, all P〈0.01). The expression of Bax was increased in epritseride group (390± 167) and in finasteride group (311±155) than in physiological saline group (185±73, F=6.35, P=0. 004). There were no significant differences of the expressions of 5 alpha-reductase (type 1 and type 2) mRNA among the three groups (F=0. 427 and 1.58 respectively, both P〉0.05). Conclusions Epristeride may induce apoptosis of prostate cell, inhibit angiogenesis and reduce MVD, but it has no effect on the expressions of 5 alpha reductase (type 1 and type 2) mRNA, being similar with finasteride.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2009年第12期1029-1032,共4页 Chinese Journal of Geriatrics
关键词 前列腺增生 基因表达 一氧化氮 氧化还原酶类 酶抑制剂 Prostatic hyperplasia Gene expression Nitric oxide synthase Oxidoreductases Enzyme inhibitors
  • 相关文献

参考文献11

  • 1李宁忱,那彦群,丁强,张元芳,吴宏飞,杨宇如,鲁功成,郭应禄.新型5α-还原酶抑制剂爱普列特治疗良性前列腺增生的Ⅳ期临床研究[J].中华泌尿外科杂志,2002,23(7):413-416. 被引量:33
  • 2范民,汪良.爱普列特治疗良性前列腺增生临床疗效观察[J].临床泌尿外科杂志,2008,23(2):127-128. 被引量:11
  • 3王晓东,贾悦,崔毓桂,王兴海,童建孙,马鼎志,蔡瑞芬,狄福松.大剂量5α还原酶抑制剂对雄性大鼠生精功能的影响[J].中华男科学杂志,2005,11(9):652-654. 被引量:3
  • 4QIAN LH, WANG XL, TU ZH, et al. Atrophy and apoptosis in ventral prostate of rats induced by 5a-reductase inhibitor, epristeride. Acta Pharmacologica Sinica, 2001, 22: 399-404.
  • 5吴海涵,翁志梁,李湘斌,陈伟,蔡冰,李澄棣.5α-还原酶抑制剂治疗对前列腺增生患者血清性激素水平的影响[J].中国男科学杂志,2007,21(3):44-46. 被引量:6
  • 6Vaarala MH, Lukkarinen O, Marttila T, et al. Prostatic expression of human 5alpha-reductase type 2 during finasteride therapy: a randomized, double-blind, placebo-controlled study. World J Urol, 2000, 18:406 410.
  • 7Ogorzaly L, Gantzer C. Development of real-time RT-PCR methods for specific detection of F-specific RNA bacteriophage genogroups: application to urban raw wastewater. J Virol Methods, 2006, 138: 131-139.
  • 8Jankson MW,Bentel JM, Tilley WD, et al. Vascular endothelial growth factor expression in prosate cancer and benign prostatic hyperplasia. J Urol, 1997, 157:2323-2328.
  • 9Babaei S, Stewart DJ. Overexpression of endothelial NO synthase induces angiogenesis in a co2-culture model. Cardiovasc Res, 2002, 55.190-200.
  • 10Gradini R, Realacci M,Ginepri A, et al. Nitric oxide synthases in normal and benign hyperlastic human prostate : immunohistoehemistry and molecular biology. J Pathol, 1999, 189:224-229.

二级参考文献31

  • 1王晓东,贾悦,崔毓桂,狄福松,王兴海,童建孙,马鼎志,蔡瑞芬.爱普列特对雄性大鼠生精功能的影响[J].药学进展,2002,26(1):58-60. 被引量:3
  • 2崔毓桂.5α-还原酶的分子生物学研究[J].国外医学(计划生育分册),1994,13(2):101-103. 被引量:3
  • 3林宁,许烨.介绍一种测定大鼠附睾精子活率和密度的改进方法[J].实用男科杂志,1996,2(3):183-184. 被引量:14
  • 4郑德先,中华病理学杂志,1996年,25卷,50页
  • 5邓方明,中华外科杂志,1996年,34卷,620页
  • 6邓方明,中华泌尿外科杂志,1995年,16卷,729页
  • 7O' Donnell L, Pratis K, Stanton PG, et al. Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5 alpha-reductase inhibitor[J]. J Androl, 1999, 20(1): 109-117.
  • 8O' Donnell L, Stanton PG, Wreford NG, et al. Inhibition of 5 alpha-reductase activity impairs the testosterone-dependent restoration of spermiogenesis in adult rats[J]. Endocrinology, 1996, 137(7): 2703-2710.
  • 9Cai LQ, Fratianni CM, Gautier T, et al. Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency[J]. J Clin Endocrinol Metab, 1994, 79(2): 409-414.
  • 10Anderson RA, Kelly RW, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V. Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone[J]. J Androl, 1997, 18(4): 366-371.

共引文献60

同被引文献7

  • 1余凯远,翁志梁,王思齐,余志贤,陈伟,吴秀玲,李澄棣.间歇性与持续性雄激素阻断治疗晚期前列腺癌疗效比较[J].中华泌尿外科杂志,2006,27(11):761-764. 被引量:31
  • 2Qlan LH, Wang XL, Tu ZFI, et al. Atro- phy and apoptosis in ventral prostate of rats induced by 5a-reductase inhibitor, epristeride[J]. Acta Pharmacologica Sin- ica, 2001, 22(5): 399-404.
  • 3Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004[J]. CA Cancer J Clin 2004, 54(1): 8-29.
  • 4Sato N, Gleave ME, Bruchovsky N, et al. Intermittent androgen suppression delays progression to androgen-independent regu- lation of prostate-specific antigen gene in the LNCaP prostate tumour model[J]. J Steroid Biochem Mol Biol, 1996,58(2): 139-146.
  • 5Scholz MC, Jennrich ILl, Strum SB, et al. Termittent use of testosterone inactivating pharmaceuticals using finasteride pro- longs the time off period[J]. J Urol, 2006, 175(5): 1673-1678.
  • 6Locke JA, Bruchovsky N. Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy[J]. Can J Urol, 2010, 17(3):5162-5169.
  • 7陈伟,翁志梁,余凯远,李叶平,邓哲宪,吴海涵,吴秀玲,李澄棣.非那雄胺在晚期前列腺癌间歇性雄激素阻断治疗间隙期的应用[J].中华老年医学杂志,2008,27(11):815-817. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部